Zoetis Announces The Completion Of Jurox Animal Health, A Leading Provider Of Livestock And Companion Animal Products, Based In Australia
3rd October, 2022 13h06
Zoetis Ltd today announced it has completed the acquisition of Jurox, a privately held animal health company, which develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals. Jurox’s operations are based in Australia, with additional regional offices in New Zealand, U.S., Canada and the UK. Financial terms of the transaction are not being disclosed.
The acquisition of Jurox brings Zoetis a range of important products primed for greater global expansion; a valuable animal health portfolio, including Alfaxan®, a leading anaesthetic product for companion animals; and high-quality local R&D and manufacturing operations in Australia, a critical addition to support further growth and innovation.
Stephanie Armstrong, Senior Vice President and Cluster Lead UK, BeNeLuX, Nordics & Ireland, said: “We are grateful to the O’Brien family for entrusting the future of this family-owned business to Zoetis. Jurox’s portfolio plays to the strengths of our core business and will be a complementary fit with the solutions we deliver to veterinary professionals, livestock producers and pet owners. With Zoetis’ global sales and regulatory expertise in more than 45 direct markets, we look forward to expanding the impact and reach of the entire Jurox portfolio here in the UK and Ireland.”
Jurox develops and manufactures more than 150 products in areas such as parasiticides, anti-infectives, anaesthesia, cardiology, and reproduction for animals.
“Jurox and Zoetis share similar beliefs about the important role animal health plays for the world, as well as the high standards we must keep to bringing meaningful solutions to our customers,” said Jurox Country Manager UK & Ireland, Richard Beckwith. “We look forward to the future Jurox and Zoetis can build together in the UK and around the world.”
More from Zoetis
- Zoetis hosts free Webinar for RAMAs/SQPs, Vets and Vet Nurses on best practice use of anthelmintics in horses
- Zoetis acquires NewMetrica
- APOQUEL® chewable tablets (oclacitinib) are now available from all UK Veterinary Wholesalers
- Zoetis Celebrates A.L.P.H.A. Initiative’s Five-Year Anniversary and Progress Toward Improved Livestock Health and Farmers’ Livelihoods in Sub-Saharan Africa
- Zoetis selected for OIE Rabies Vaccine Bank